A Nobel-Winning Scientist: Aziz Sancar and the Impact of his Work on the Molecular Pathology of Neoplastic Diseases.


Creative Commons License

Pehlivanoglu B., Aysal A., Kececi S. D., Ekmekci S., Erdogdu I. H., Ertunc O., ...More

Turk patoloji dergisi, vol.37, no.2, pp.93-105, 2021 (ESCI) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 37 Issue: 2
  • Publication Date: 2021
  • Doi Number: 10.5146/tjpath.2020.01504
  • Journal Name: Turk patoloji dergisi
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.93-105
  • Keywords: Aziz Sancar, Carcinogenesis, Molecular Pathology, Nobel prize, Neoplasia, NUCLEOTIDE-EXCISION-REPAIR, COLI DNA PHOTOLYASE, BLUE-LIGHT PHOTORECEPTORS, ENCODING CPD-PHOTOLYASE, STRAND-SPECIFIC REPAIR, ESCHERICHIA-COLI, CIRCADIAN CLOCK, PARTIAL-PURIFICATION, ACTION MECHANISM, RNA-POLYMERASE
  • Süleyman Demirel University Affiliated: Yes

Abstract

Aziz Sancar, Nobel Prize winning Turkish scientist, made several discoveries which had a major impact on molecular sciences, particularly disciplines that focus on carcinogenesis and cancer treatment, including molecular pathology. Cloning the photolyase gene, which was the initial step of his work on DNA repair mechanisms, discovery of the “Maxicell” method, explanation of the mechanism of nucleotide excision repair and transcription-coupled repair, discovery of “molecular matchmakers”, and mapping human excision repair genes at single nucleotide resolution constitute his major research topics. Moreover, Sancar discovered the cryptochromes, the clock genes in humans, in 1998, and this discovery led to substantial progress in the understanding of the circadian clock and the introduction of the concept of “chrono-chemoterapy” for more effective therapy in cancer patients. This review focuses on Aziz Sancar’s scientific studies and their reflections on molecular pathology of neoplastic diseases. While providing a new perspective for researchers working in the field of pathology and molecular pathology, this review is also an evidence of how basic sciences and clinical sciences complete each other.

Key Words: Aziz Sancar, Carcinogenesis, Molecular Pathology, Nobel prize, Neoplasia